Decrease of allergen-specific T-cell response induced by local nasal immunotherapy

Clinical and Experimental Allergy

Volumn 28, Issue 4, 1998, Pages 404-412

  Giannarini, L ^a   Maggi, E ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b III Clinical Immunology Unit   (Italy)

Author keywords

Allergic rhinitis; Cytokines; Grass specific IgE and IgG antibodies; Local immunotherapy; Rye group 1 allergen; Short term T cell lines; Subcutaneous immunotherapy; Symptom score; T cell proliferation; TH1 TH2 cell subsets

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; RECOMBINANT INTERLEUKIN 2; STREPTOKINASE;

ALLERGIC RHINITIS; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; MALE; POLLEN ALLERGY; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RHINITIS; SCORING SYSTEM;

ADMINISTRATION, INTRANASAL; ADULT; ALLERGENS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODY FORMATION; CELL DIVISION; CYTOKINES; EPITOPES; FEMALE; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOTHERAPY; INJECTIONS, SUBCUTANEOUS; MALE; PLANT PROTEINS; RHINITIS, ALLERGIC, SEASONAL; T-LYMPHOCYTES; TREATMENT OUTCOME;

EID: 0031902762     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1998.00265.x     Document Type: Article

References (42)

1. Norman PS. Specific therapy in allergy. Med Clin North Am 1974; 58:111-25.
2. Creticos PS. Immunotherapy with allergens. JAMA 1992; 268:2834-9.
3. Mailing H-J, Weeke BEAACI. Position Paper. Immunotherapy Allergy 1993; 48:9-35.
4. Aalberse RL, Van der Gaag R, Van Leeuwen J. Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4 restricted response. J Immunol 1983; 130:722-6.
5. Gleich GJ, Jacob GL, Yunginger JW, Henderson LL. Measurement of the absolute levels of IgE antibodies in patients with ragweed hay fever. Effect of immunotherapy on seasonal changes and relationship to IgG antibodies. J Allergy Clin Immunol 1977; 60:188-98.
6. Chapman MD, Platts-mills TAE, Gabriel M et al. Antibody response following prolonged hyposensitization with Dermatophagoides pteronyssinus exstract. Int Arch Allergy Appl Immunol 1980; 61:431-40.
7. McMenamin C, Holt P. The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production. J Exp Med 1993; 178:889-99.
8. Carballido JM, Perrig-Carballado N, Terres G, Heusser CH, Blaser K. Bee venom phospholipase A2-specific T cell clones from human allergic and non-allergic individuals: cytokines patterns change in response to the antigen concentration. Eur J Immunol 1992; 22:1357-63.
9. Secrist H, Chelen CJ, Wen Y, Marshall JD, Umetsu DT. Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. J Exp Med 1993; 178:2123-30.
10. Jutel M, Pichler WJ, Skrbic D et al. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen-stimulated T cell cultures. J Immunol 1995; 154:4187-94.
11. McHugh SM, Deighton J, Stewart AG, Lachman PJ, Ewan PW. Bee venom immunotherapy induces a shift in cytokine responses from TH-2 to TH-1 dominant pattern: comparison of rush and conventional immunotherapy. Clin Exp Allergy 1995; 25:828-38.
12. Nickelsen JA, Goldstein S, Mueller U et al. Local intranasal immunotherapy for ragweed allergic rhinitis. J Allergy Clin Immunol 1981; 68:41-5.
13. Taylor G, Shivalkar PR. Local nasal desensitization in allergic rhinitis. Clin Allergy 1972; 2:125-36.
14. Andri L, Senna G, Betteli C, Givanni S, Andri G, Falagiani P. Local nasal immunotherapy for dermatophagoides-induced rhinitis: efficacy of a powder extract. J Allergy Clin Immunol 1993; 91:987-96.
15. Andri L, Senna G, Andri G et al. Local nasal immunotherapy for birch allergic rhinitis with extract in powder form. Clin Exp Allergy 1995; 25:1092-9.
16. Bardare M, Zani G, Buschini MP et al. Nasal hyposensitization with a grass pollen extract in children affected with rhinocon-junctivitis. N Engl Reg Allergy Proc 1988; 9: (abst) 257.
17. Andri L, Senna GE, Betteli C et al. Local nasal immunotherapy in allergic rhinitis to parietaria. A double blind controlled study. Allergy 1992; 47:318-23.
18. Ariano R, Panzani RC, Chiapella M, Augeri G, Falagiani P. Local immunotherapy of seasonal allergic rhinitis in children due to Parietaria officinalis pollen: a preliminary report. Pediatrie Asthma, Allergy Immunol 1993; 7:227-37.
19. D'Amato G, Lobefalo G, Liccardi G, Cazzola MA. Double-blind, placebo-controlled trial of local nasal immunotherapy in allergic rhinitis to Parietaria pollen. Clin Exp Allergy 1995; 25:141-8.
20. Ariano R, Panzani RC, Chiapella M, Augeri G, Falagiani P. Local nasal immunotherapy with allergen in powder in atopic patients sensitive to Parietaria officinalis pollen. J Invest Allergol Clin Immunol 1995; 5:126-32.
21. Passalacqua G, Albano M, Ruffoni S et al. Nasal immunotherapy to Parietaria: evidence of reduction of local allergic inflammation. Am J Resp Crit Care Med 1995; 152:461-6.
22. Cirla AM, Sforza N, Roffi GP et al. Preseasonal intranasal immunotherapy in birch-alder allergic rhinitis. A double blind study. Allergy 1996; 51:299-305.
23. Johansson SCO, Deushl H, Zetterstrom O. The use of glutaraldehyde modified timoty grass pollen extract in nasal hyposensitization treatment of hay fever. Int Arch Allergy Appl Immunol 1979; 50:447-60.
24. Gurgenidze GV, Baraban EI, Gamkreilidze AG. Comparative estimation of general and local humoral immunity indicators in connetion with local immunotherapeutic treatment. Allergol Immunopathol 1990; 18:325-9.
25. Georgitis JW, Nickelsen JA, Wypych JI, Barde SH, Clayton WF. Reisman RE. Local nasal immunotherapy with high doses of polymerized ragweed extract. Int Arch Allergy Appl Immunol 1986; 81:170-3.
26. Mathews KP, Bayne NK, Banas JM, McLean JA, Bacon J. Controlled studies of intranasal immunotherapy for ragweed pollenosis. Int Arch Allergy Appl Immunol 1981; 66:218-24.
27. Welsh SB, Zimmerman EM, Yunginger JW, Kern EB, Gleich GJ. Preseasonal intranasal immunotherapy with nebulized short ragweed extract. J Allergy Clin Immunol 1981; 67:237-42.
28. Andri L, Senna GE, Betteli C et al. Local nasal immunotherapy with extract in powder form is effective and safe in grass pollen rhinitis: a double-blind study on 32 patients. J Allergy Clin Immunol 1996; 97:34-41.
29. Olivieri V, Becearini I, Gallucci G, Romuno T, Santoro S. Capture assay for specific IgE. An improved quantitative method. J Immunol Meth 1993; 157:65-72.
30. Parronchi P, Macchia D, Piccinni MP et al. Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine secretion. Proc Natl Acad Sci (USA) 1991; 88:4538-42.
31. Maggi E, Mazzetti M, Ravina A et al. Ability of HIV to promote a Th1 to Th2 shift and to replicate preferentially in Th2 and Th0 cells. Sci 1994; 265:244-8.
32. Evans R, Pence H, Kaplan H, Rocklin RE. The effect of immunotherapy on humoral and cellular responses in ragweed hay fever. J Clin Invest 1976; 57:1378-85.
33. Fasler S, Aversa G, Terr A et al. Peptide-induced anergy in allergen-specific human Th2 cells results in lack of cytokine production and B cell help for IgE synthesis. Reversal by IL-2, not IL-4 or IL-13. J Immunol 1995; 155:4199-206.
34. Van Neerven RJJ, Ebner C, Yssel H, Kapsenberg ML, Lamb JR. T-cell responses to allergens: epitope-specificity and clinical relevance. Immunol Today 1996; 17:526-32.
35. Secrist H, Dekruyff RH, Umetsu DT. Interleukin 4 production by CD4+ T cells from allergic Individuals is modulated by antigen concentration and antigen-presenting cell type. J Exp Med 1995; 181:1081-9.
36. Brunner T, Heusser CH. Dahinden CA. Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J Exp Med 1993; 177:605-11.
37. Imada M, Estelle F, Simons R, Jay FT, Hayglass KY. Allergen-stimulated interleukin-4 and interferon-γ production in primary culture: responses of subjects with allergic rhinitis and normal controls. Immunol 1995; 85:373-80.
38. Hosken NA, Shibuya K, Heath AW, Murphy KM, O'Gurra A. The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-α/β -transgenic model. J Exp Med 1995; 182:1579-84.
39. Hoyne GF, O'Hehir RE, Wraith DC et al. Inhibition of T cell and antibody response to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice. J Exp Med 1993; 178: 1783-8.
40. Hoyne GF, Kristensen N, Yssel H et al. Peptide modulation of allergen-specific immune responses. Curr Opin Iinmunol 1995; 7:757-61.
41. Mistrello G, Rapisarda G, Falagiani P, Detection of IgE-binding activity in serum after intranasal treatment of normal rabbits with Parietaria judaica extract. Allergy 1991; 46:52-8.
42. Bagnasco M, Mariani G, Passalacqua G et al. Absorption and distribution of the major Parietaria judicae allergen (Parj 1) administered by non-injectable routes in healthy human beings. J Allergy Clin Immunol 1997; 100:121-9.